Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $24.3100 (-3.86%) ($24.0350 - $24.3100) on Fri. Oct. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.08% (three month average) | RSI | 41 | Latest Price | $24.3100(-3.86%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.9% a day on average for past five trading days. | Weekly Trend | IOVA declines -2.3% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(44%) XBI(40%) IWO(39%) ARKG(38%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.54% in a week (0% probabilities). VIXM(-23%) UUP(-15%) VXX(-10%) TBT(-6%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.54% (StdDev 3.08%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $26.05 | 5 Day Moving Average | $25.51(-4.7%) | 10 Day Moving Average | $25.63(-5.15%) | 20 Day Moving Average | $26.05(-6.68%) | To recent high | -12% | To recent low | 18.5% | Market Cap | $3.56b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |